Letter

Payment for treatment adherence

Incentives help vulnerable patients to stay well

BMJ 2007; 335 doi: 10.1136/bmj.39303.690752.3A (Published 16 August 2007)
Cite this as: BMJ 2007;335:317.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Sue Collinson, TB case worker
  1. Homerton University Hospital, London E9 6SR
  1. sue.collinson{at}homerton.nhs.uk

    In the head to head debate, Shaw says that to pay patients to take medication would create perverse incentives, but in her discussion she dismisses a particularly complex group of patients, with tuberculosis, despite the public health issues involved.1 2 This is a group of patients for whom payment, or other forms of incentive, are of critical importance, at both the individual and …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular